US Material Events SEC 8-K Filings — April 02, 2026

02-04-2026

Suncrete, Inc. entered into a Securities Exchange Agreement dated March 26, 2026, to acquire all 26,000,000 Senior Preferred Units of Concrete Partners Holding, LLC from Exchanging Holders in exchange for 26,000 shares of its Series A Convertible Perpetual Preferred Stock at a ratio of 1 share per 1,000 units. The exchange is scheduled to close immediately prior to the Acquisition Merger under the October 9, 2025 Business Combination Agreement with Haymaker Acquisition Corp. 4, with accrued dividends paid in cash beforehand and the transaction structured for tax-deferred treatment under IRC Section 351. No financial valuations or performance metrics are disclosed.

• ·Exchange relies on Section 4(a)(2) of the Securities Act and Rule 506(b) exemption for unregistered issuance to accredited investors.
• ·Permitted under Credit Agreement dated July 29, 2024, as amended October 17, 2025 and subsequently.
• ·Series A Certificate of Designation to be filed with Delaware Secretary of State prior to closing.
• ·Upon closing, all obligations under CPH's Amended and Restated LLC Agreement dated July 29, 2024 are terminated.

02-04-2026

Caris Life Sciences, Inc. entered into a new senior secured Financing Agreement on April 1, 2026, providing a $400,000,000 initial term loan (funded at closing), up to $300,000,000 delayed draw term loan facility (available through August 2027 for permitted acquisitions), and an uncommitted $500,000,000 incremental facility, with lenders including funds managed by Blue Owl Capital and Blackstone. Proceeds from the initial term loan fully repaid and terminated the prior credit agreement dated January 18, 2023. The new facility matures in April 2031, carries interest margins of Term SOFR + 5.00% or Base Rate + 4.00%, and requires maintenance of at least $50,000,000 in minimum qualified cash quarterly.

• ·Obligations guaranteed by certain subsidiaries and secured on a first-priority basis by substantially all tangible and intangible personal property, including pledges of subsidiary capital stock.
• ·New Credit Agreement contains customary covenants limiting debt incurrence, liens, investments, asset dispositions, affiliate transactions, and prepayments of certain indebtedness.
• ·Events of default include payment failures, covenant breaches, bankruptcy, and change of control, allowing lender acceleration.

02-04-2026

Optimum Communications, Inc. (OPTU) announced that Michael E. Olsen, Executive Vice President, General Counsel and Chief Corporate Responsibility Officer, will transition from his current role effective October 1, 2026 (or earlier upon successor appointment) to Senior Executive Counsel, Capital Transformation through December 31, 2027, after which he will retire. Under the Transition, Retention and Retirement Agreement dated April 1, 2026, Mr. Olsen will receive a $3,575,000 lump-sum cash retention payment, fully earned on December 31, 2027, subject to continued employment, with no repayment required in qualifying terminations (e.g., without cause, good reason, death, or disability). Through the Transition Date, he continues current base salary and incentive eligibility; post-transition, base salary, benefits, and vesting continue but no new incentives.

• ·In qualifying termination prior to December 31, 2027, entitled to lump sum base salary through that date and continued vesting of long-term incentive awards, subject to separation agreement and covenants.
• ·Transition Agreement provides continued indemnification, D&O insurance coverage, and customary confidentiality, non-disparagement, and restrictive covenants.
• ·Full Transition Agreement to be filed with Quarterly Report on Form 10-Q.

02-04-2026

Ashford Hospitality Trust completed the sale of the 252-room Hilton Alexandria Old Town on March 31, 2026, receiving $57.3 million in cash net of selling expenses while repaying $32.5 million in associated mortgage debt, netting approximately $24.8 million in cash. Pro forma balance sheet as of December 31, 2025, reflects reduced total assets of $2,797,150 thousand (down from $2,833,632 thousand) and net hotel properties of $2,024,994 thousand (down $60,250 thousand). Pro forma statement of operations for the year ended December 31, 2025, shows revenue declining 1.6% to $1,087,001 thousand from $1,104,388 thousand, but net loss improving to $157,318 thousand from $188,159 thousand after removing the hotel's $34,010 thousand loss, offset by a $2,993 thousand non-recurring disposition loss.

• ·Pro forma basic and diluted loss per share improved to $(30.90) from historical $(35.99).
• ·Hilton Alexandria contributed $17,387 thousand in total hotel revenue but a $28,388 thousand operating loss and $31,484 thousand in impairment charges for the year ended Dec 31, 2025.
• ·Pro forma net income (loss) attributable to common stockholders $(184,604) thousand vs historical $(215,004) thousand.

02-04-2026

On March 27, 2026, American Bridge Company, a wholly owned subsidiary of Southland Holdings, Inc., entered into a Settlement Agreement with Clark/Lewis JV, Sureties, Washington State Convention Center, and others, resolving disputes and litigation (King County Superior Court Cause No. 22-2-19603-3 SEA) from the WSCC expansion project. Sureties previously paid $57.8 million for the Merits Judgment (principal ~$57.1 million plus interest) and will pay an additional ~$26.5 million (~$25.5 million for costs/fees/interest, $1.0 million for sanctions). While the settlement provides broad mutual releases and dismissals, it imposes financial obligations consistent with prior estimates, with Sureties forbearing repayment until at least March 27, 2027, amid ongoing negotiations.

• ·Litigation: King County Superior Court Cause No. 22-2-19603-3 SEA
• ·Settlement reserves rights for American Bridge’s appeal of sanctions order
• ·Sureties to receive assignment of Merits Judgment; dismissals with prejudice to follow Satisfaction of Judgment filing
• ·Agreement filed as exhibit to Q1 2026 10-Q
• ·No assurances on final long-term financing agreement for Sureties repayment

02-04-2026

Nuveen Churchill Private Capital Income Fund (PCAP) announced it will acquire 100% of the assets and liabilities of Nuveen Churchill BDC V (BDC V) at fair value (net asset value), with the transaction expected to close in Q2 2026 subject to shareholder approval and customary conditions. The deal is anticipated to enhance PCAP's scale, portfolio diversification (top 10 investments dropping from ~11% to ~9% of portfolio), and operational efficiencies, with BDC V's complementary portfolio showing 55% asset overlap, no non-accrual investments, and a weighted average internal risk rating of 4.0 as of December 31, 2025. While positioned for long-term value, the transaction carries risks including potential failure to close, shareholder rejection, and economic disruptions.

• ·BDC V commenced operations in August 2025.
• ·Transaction consideration: cash equal to BDC V’s NAV as of a date no earlier than 48 hours prior to closing.
• ·PCAP and BDC V focus on U.S. middle market companies with $10 to $100 million EBITDA.
• ·Proxy statement to be filed by BDC V for shareholder approval of transaction and BDC election withdrawal.

02-04-2026

OS Therapies completed a $5.25M registered direct offering of common stock and warrants primarily with pre-existing high-net-worth investors at $1.40 per share, with net proceeds plus approximately $4M in expected non-dilutive funds ($2M VAT refunds in 2Q-26 and $2M R&D tax credits in 2H-26) from its U.K. subsidiary providing cash runway into 2027. The company anticipates U.S., U.K., and Europe approvals for OST-HER2 in preventing recurrent pulmonary metastatic osteosarcoma in H2 2026, with upcoming regulatory meetings this quarter and potential eligibility for a Priority Review Voucher (PRV). OST-HER2 holds multiple designations including FDA ODD, FTD, RPDD and EMA ODD, FTD, ATMP, though PRV sale value is uncertain (recent example $205M).

• ·OST-HER2 received Orphan Drug Designation (ODD), Fast Track Designation (FTD), and Rare Pediatric Disease Designation (RPDD) from FDA; ODD, FTD, and ATMP from EMA.
• ·U.K. subsidiary established in 2025 for R&D.
• ·OST-HER2 conditionally approved by USDA for canines with osteosarcoma.
• ·Phase 1b study of OST-504 in castration resistant prostate cancer data expected H1 2026.
• ·Shelf registration on Form S-3 (File No. 333-289443) effective August 25, 2025.

02-04-2026

FGI Industries Inc., a subsidiary of FGI Industries Ltd., entered into an Amended and Restated Business Loan Agreement (Asset Based) with East West Bank on March 27, 2026, providing for a line of credit with advances available up to the Borrowing Base, subject to conditions precedent including perfection of security interests in collateral such as accounts receivable and inventory. The agreement is secured by liens on Borrower's assets, requires ongoing compliance certificates and audits, and continues until all obligations are paid in full. No specific loan amounts or borrowing limits were disclosed in the filing.

• ·SEC 8-K filing dated April 02, 2026, covering Items 1.01 (Entry into Material Definitive Agreement), 2.03 (Creation of Direct Financial Obligation), and 9.01 (Financial Statements and Exhibits).
• ·Collateral includes Accounts, Inventory, and related proceeds; Lender has rights to audit, notify account debtors, and collect payments directly.
• ·Conditions precedent include execution of related documents such as Note, Security Agreements, Guaranties, and perfection certificates.

02-04-2026

Kodiak Gas Services, Inc. (NYSE: KGS) completed the acquisition of Distributed Power Solutions, LLC (DPS) on April 1, 2026, for $587 million in cash and approximately 2.4 million shares of common stock, adding 395 megawatts of generation capacity and expanding into distributed power solutions for data centers, microgrids, manufacturing, and energy infrastructure. The acquisition is expected to be immediately accretive to earnings and discretionary cash flow per share, while extending contracted cash flows. No negative financial impacts or declines were reported.

• ·DPS rebranded as Kodiak Power Solutions, a division of Kodiak Gas Services.
• ·Integration activities underway focusing on service continuity, operational excellence, and safety.
• ·Headquartered in The Woodlands, Texas.

02-04-2026

On April 1, 2026, Clearway Energy LLC, Clearway Energy, Inc., and Clearway Energy Group LLC entered into a Third Amended and Restated Exchange Agreement, amending the prior Second Amended Exchange Agreement dated October 28, 2024. The amendment changes the exchange terms, allowing CEG Unitholders to exchange Class B units of Clearway Energy LLC for shares of Class C common stock of Clearway Energy, Inc. (instead of Class A common stock) on a one-for-one basis, subject to equitable adjustments, with corresponding extinguishment of Class B common stock shares. The full agreement is attached as Exhibit 10.1.

• ·Agreement amends and restates the Second Amended Exchange Agreement dated October 28, 2024.
• ·Exchanges remain on a one-for-one basis, subject to equitable adjustments for stock splits, stock dividends, and reclassifications.
• ·Filing date: April 2, 2026; Date of earliest event: April 1, 2026.

02-04-2026

Terra Property Trust, Inc. completed its exchange offers on March 30, 2026, exchanging $24,027,025 of 6.00% unsecured Senior Notes due June 30, 2026, and $1,550,975 of 7.00% unsecured Senior Notes due March 31, 2026 issued by subsidiary TIF6, for $25,578,000 aggregate principal of new 7.00% Senior Secured Notes due March 31, 2029, secured by equity interests in 18 subsidiaries. The new notes carry a 7% interest rate payable monthly starting April 30, 2026, with covenants limiting additional debt and dividends unless a Collateral Coverage Ratio of at least 1.35:1.00 is maintained; no subsidiary guarantees were provided as of issuance.

• ·Exchange Offers expired March 26, 2026, with final settlement on March 30, 2026; TIF6 repaid remaining TIF6 Notes principal on March 31, 2026.
• ·Exchange Notes redeemable at 101% prior to December 31, 2026, and 100% thereafter, plus accrued interest.
• ·Indenture filed as Exhibit 4.1; no requirement to offer purchase on change of control.

02-04-2026

On April 1, 2026, Clearway Energy, Inc., Clearway Energy LLC, and Clearway Energy Group LLC entered into a Third Amended and Restated Exchange Agreement, amending the prior agreement dated October 28, 2024. The amendment changes the exchange provision so that CEG Unitholders may now exchange Class B units of Clearway Energy LLC for shares of Class C common stock (previously Class A common stock) on a one-for-one basis, with corresponding Class B common stock shares extinguished upon exchange. No financial terms or impacts are disclosed in the filing.

• ·Exchange remains subject to equitable adjustments for stock splits, stock dividends, and reclassifications.
• ·Agreement filed as Exhibit 10.1.

02-04-2026

CareView Communications, Inc., along with its subsidiary Borrower, PDL Investment Holdings, LLC as Lender, Steven G. Johnson (President and CEO), and Dr. James R. Higgins (director), entered into the Fourteenth Amendment to the Credit Agreement on March 30, 2026, extending the Maturity Date to June 30, 2026. This amendment continues a long series of prior modifications to the original June 26, 2015 Credit Agreement and related Modification Agreement, with dozens of amendments listed dating back to 2015. The update creates or modifies a direct financial obligation under Item 2.03.

• ·Original Credit Agreement dated June 26, 2015
• ·Filing incorporates 30+ prior amendments to Credit Agreement and Modification Agreement as exhibits, with latest prior ones in December 2025

02-04-2026

Service Properties Trust amended its Declaration of Trust, effective March 30, 2026, to increase total authorized shares of beneficial interest from 300,000,000 to 1,000,000,000, with Common Shares rising from 200,000,000 to 900,000,000 (+350%) while Preferred Shares remain at 100,000,000 (flat). The aggregate par value for Preferred Shares increased from $2,000,000 to $9,000,000 (+350%). The amendment was approved solely by the Board of Trustees, with no shareholder approval required under Maryland REIT Law.

• ·Amendment filed as Exhibit 3.1 in 8-K on April 02, 2026, covering Items 1.01, 5.03, 9.01.
• ·Common Shares have $0.01 par value per share; Preferred Shares without par value.
• ·No shareholder approval required per Section 8-203(a)(8) of Maryland REIT Law and Article V, Section 5.1 of Declaration.

02-04-2026

Global Net Lease, Inc. (GNL) announced that board members Sue Perrotty and Governor Edward Rendell will retire effective immediately following the 2026 Annual Meeting of Stockholders and will not stand for re-election. They provided 11 and 14 years of service, respectively, including leadership through the 2023 merger and internalization. Post-meeting, the Board will consist of eight members if all nominees are elected.

• ·GNL is a publicly traded internally managed REIT (NYSE: GNL) focused on net lease assets in the U.S., Western and Northern Europe.
• ·Investor Relations contact: investorrelations@globalnetlease.com or (323) 265-2020.

02-04-2026

ESAB Corporation announced the appointment of R. Brent Jones as Chief Financial Officer effective early May 2026, succeeding Kevin Johnson who is departing to pursue a CFO role at a privately held company, with Johnson assisting in the transition. Jones brings over three decades of experience, including prior CFO roles at Avantor and Pall Corporation. Despite recent geopolitical events, ESAB reaffirms its previously announced 2026 guidance ranges for total core sales, aEBITDA, and aEPS.

• ·ESAB founded in 1904, based in North Bethesda, Maryland, serves customers in approximately 150 countries
• ·Kevin Johnson's tenure at ESAB: past seven years

02-04-2026

Flutter Entertainment plc announced that independent Director Alfred F. Hurley, Jr., who has served since June 2016, will retire after a ten-year term and not stand for re-election at the 2026 Annual General Meeting on May 29, 2026. John Bryant, Chair of the Board, thanked Hurley for his contributions, including during the U.S. listing transition and as Chair of the Compensation and Human Resources Committee. Effective post-AGM, Nancy Dubuc will replace Hurley as Chair of the Compensation and Human Resources Committee.

• ·Flutter notified the Board of Hurley's retirement decision.
• ·Enquiries: Edward Traynor, +353872232455

02-04-2026

Sally Beauty Holdings, Inc. (NYSE: SBH) appointed Adrianne Lee as Senior Vice President and Chief Financial Officer effective April 28, 2026, succeeding Marlo Cormier, who will depart effective April 11, 2026, to pursue other opportunities. Ms. Lee brings extensive finance leadership experience from Bed Bath & Beyond, The Hertz Corporation, and other firms. The Company reaffirmed its previously issued second quarter and fiscal year 2026 financial guidance.

• ·Adrianne Lee previously served as President and CFO at Bed Bath & Beyond, joining as CFO in 2020
• ·Guidance for Q2 and FY2026 originally provided on February 9, 2026
• ·Sally Beauty operates through Sally Beauty and Beauty Systems Group segments

02-04-2026

On March 31, 2026, Leiden Dworak notified TScan Therapeutics, Inc. of his resignation as Vice President of Finance and principal accounting officer, effective April 10, 2026, with no disagreements on operations, policies, or practices. The Board of Directors appointed Jason A. Amello, the current Chief Financial Officer and principal financial officer, as the new principal accounting officer effective the same date. Mr. Amello will receive no additional compensation for the role, and no changes were made to his existing plans or arrangements.

• ·Resignation notification date: March 31, 2026
• ·Effective date of resignation and appointment: April 10, 2026
• ·Mr. Amello's background incorporated by reference from definitive proxy statement on Schedule 14A filed May 14, 2025

02-04-2026

Oportun Financial Corporation announced that Kate Layton (Chief Legal Officer and Corporate Secretary) and Gaurav Rana (General Manager of Lending) will jointly lead as interim CEOs effective April 4, 2026, following the previously announced departure of Raul Vazquez as CEO and Board member. Vazquez will serve as an advisor until July 3, 2026, while the Board advances its search for a permanent CEO. Lead Independent Director Louis P. Miramontes highlighted progress in the CEO selection process and praised the interim leaders' deep business knowledge.

• ·Kate Layton joined Oportun in 2015, previously Deputy General Counsel and Corporate Secretary.
• ·Gaurav Rana joined Oportun in 2017 as Head of Data and Analytics.
• ·Investor Contact: Dorian Hare (650) 590-4323, ir@oportun.com

02-04-2026

Abundia Global Impact Group, Inc. (formerly Houston American Energy Corp., NYSE American: AGIG) completed the acquisition of RPD Technologies Americas, LLC on April 1, 2026, integrating a revenue-generating project development firm with a team of approximately 20 employees and over 100 years of combined chemical engineering scale-up experience. This adds an immediate revenue stream to be recognized in Q2 2026 financials, establishes a new services vertical, and enhances Abundia's vertically integrated waste-to-value model with expertise in refining, petrochemicals, and renewables. The move supports long-term growth but is subject to risks including liquidity challenges and going concern uncertainties noted in forward-looking statements.

• ·RPD founded in 2019 and headquartered in Cedar Port Industrial Park, Baytown, TX
• ·RPD revenue to be recognized as total revenue in Abundia’s Q2 2026 financial statements
• ·Acquisition effective April 1, 2026

02-04-2026

Tripadvisor, Inc. announced the departure of Seth Kalvert as Chief Legal Officer and Secretary, effective May 1, 2026, treated as a Qualifying Termination under the Amended and Restated Executive Severance Plan. The departure is not due to any disagreements with the Company on operations, policies, or practices. Mr. Kalvert will remain available in an advisory capacity for transition services, with terms to be mutually agreed.

02-04-2026

Coya Therapeutics announced that founder Howard Berman, Ph.D., stepped down as Executive Chairman and Director following the November 2024 CEO transition to Arun Swaminathan, Ph.D. Mark H. Pavao, with over 30 years of biopharma commercial experience, was appointed as an independent director to fill the vacancy. The company continues advancing its lead asset COYA 302 in the Phase 2B ALSTARS trial for ALS.

• ·ALSTARS Trial: Phase 2, randomized, multi-center, double-blind, placebo-controlled study (NCT07161999)
• ·Headquartered in Houston, TX
• ·CEO transition initiated November 2024

02-04-2026

On March 27, 2026, Jones Soda Co. amended the terms of a stock option grant to its Chief Financial Officer, Brian Meadows, originally issued on September 9, 2025, for 750,000 shares of common stock under the 2022 Omnibus Equity Incentive Plan. The amendment removes prior performance milestones and establishes vesting over three years with one-third cliff vesting on each anniversary starting March 27, 2026, subject to continued employment. No other changes to officer positions or departures were reported.

• ·Amendment filed under Item 5.02 of Form 8-K
• ·Report signed by Scott Harvey on April 2, 2026

02-04-2026

On March 27, 2026, Cingulate Inc. appointed Zhanpeng “Frederick” Jiang as a Class I director, effective immediately following stockholder approval of the Issuance Proposal, to serve until the 2028 Annual Meeting. Mr. Jiang, determined to be independent, was also appointed to the Audit, Compensation, and Nominating and Corporate Governance Committees. He was granted an option to purchase 15,000 shares of common stock and annual cash retainers of $40,000 for Board service plus $7,500, $5,000, and $4,000 for committee services.

• ·Mr. Jiang's stock option has an exercise price equal to the last reported sale price on Nasdaq on grant date and vests in two equal installments over one year.
• ·Filing references prior Form 8-K dated January 28, 2026, for securities purchase agreement details.
• ·Company is an emerging growth company under Rule 405/12b-2.

02-04-2026

Bed Bath & Beyond, Inc. completed its previously announced acquisition of The Brand House Collective (TBHC) on April 2, 2026, through a merger where a wholly owned subsidiary merged with TBHC, making it a wholly owned subsidiary of BBBY. TBHC shareholders received 0.1993 shares of BBBY common stock per TBHC share, with cash payments for fractional shares based on BBBY's $4.66 closing price on April 1, 2026. In connection, BBBY contributed $30,000,000 to TBHC for general corporate purposes, including repaying indebtedness to Bank of America.

• ·Exchange Ratio: 0.1993 BBBY shares per TBHC common share
• ·TBHC options with exercise price >= $0.94 cancelled without payment
• ·TBHC RSUs fully vested and converted at Exchange Ratio
• ·Financial statements and pro forma info to be filed by amendment within 71 days

02-04-2026

On March 30, 2026, Aparna Bawa notified Zoom Communications, Inc. of her resignation as Chief Operating Officer, effective May 8, 2026. The departure is not due to any disagreement with the company. The 8-K filing was submitted on April 2, 2026, and signed by Michelle Chang, Chief Financial Officer.

• ·Company address: 55 Almaden Boulevard, 6th Floor, San Jose, California 95113
• ·Class A Common Stock ($0.001 par value) traded on Nasdaq Global Select Market under symbol ZM

02-04-2026

Ares Sports, Media & Entertainment Opportunities LP, acting as Servicer, facilitated its subsidiaries (ASME O HOLDINGS I/II/III FINCO LLC as Companies and their LP Parents) entering into a Loan and Security Agreement dated March 27, 2026, with JPMorgan Chase Bank, N.A. as Administrative Agent, The Bank of New York Mellon Trust Company, N.A. as Collateral Agent/Administrator, and various Lenders to finance Portfolio Investments in sports, media, and entertainment assets such as corporate loans, debt securities, music rights securitizations, and equity interests. The facility enables Advances for acquiring these assets via Contribution Agreements from Parents, subject to eligibility criteria, concentration limits, and market value tests. No specific commitment amounts or performance metrics are disclosed in the filing.

• ·Filing items: 1.01 (Entry into Material Definitive Agreement), 2.03 (Creation of Direct Financial Obligation), 9.01 (Financial Statements and Exhibits)
• ·Agreement effective as of March 27, 2026; SEC filing date April 02, 2026

02-04-2026

Mama’s Creations, Inc. (NASDAQ: MAMA) appointed Fred Halvin, a veteran corporate development executive with 37 years at Hormel Foods, to its Board of Directors on April 2, 2026. Halvin directed over 20 M&A transactions totaling $8 billion, including acquisitions like Planters, Columbus, Applegate, Skippy, and Muscle Milk. Chairman and CEO Adam L. Michaels praised Halvin’s expertise in acquisitions, joint ventures, and strategic growth as aligned with the company’s vision to become a premier deli solutions provider.

• ·Mama’s Creations products found in over 12,000 grocery, mass, club and convenience stores nationally.
• ·Fred Halvin previously held roles at Hormel Foods as Director of Investor Relations & EVA Analysis, Treasurer, Assistant Controller, and Corporate Tax Manager.
• ·Fred Halvin holds a B.A. in Accounting from Midland University and completed the Management Executive Program at the Carlson School of Management.

02-04-2026

FibroBiologics, Inc. (NASDAQ: FBLG) announced the pricing of a best efforts public offering of 2,272,728 shares of common stock (or equivalents) and warrants to purchase up to 2,272,728 shares at $1.32 per share and accompanying warrant. The offering is expected to generate approximately $3 million in aggregate gross proceeds before deducting placement agent fees and other expenses, with potential additional gross proceeds of approximately $3 million if the warrants are fully exercised on a cash basis, though no assurance is given that any warrants will be exercised. Closing is expected on or about April 2, 2026, subject to customary conditions, with net proceeds for working capital and general corporate purposes.

• ·Warrants exercisable beginning on effective date of stockholder approval and expire on five-year anniversary thereof
• ·H.C. Wainwright & Co. acting as exclusive placement agent
• ·Securities offered pursuant to registration statement on Form S-1 (File No. 333-294713), effective March 31, 2026
• ·Company focused on therapeutics for chronic diseases including wound healing, multiple sclerosis, disc degeneration, psoriasis, orthopedics, human longevity, and cancer

02-04-2026

Riverview Bancorp, Inc. (NASDAQ: RVSB) appointed Kourosh Zamani and Jon Girod to its Board of Directors for Riverview Bank and Riverview Bancorp, effective immediately on April 2, 2026. Zamani, co-founder of AI technology firm Laurel (raised over $150M), and Girod, owner of Quail Homes who built over 3,000 homes and developed more than 2,000 lots, bring expertise in technology, business development, and community real estate. The company reports $1.51B in assets as of December 31, 2025, with 17 branches focused on community banking.

• ·Riverview Bank is 103 years old.
• ·Named Best Bank by readers of The Columbian for the past 12 years.
• ·Headquartered in Vancouver, WA, with focus on commercial, business, and retail clients.

02-04-2026

On April 1, 2026, the Board of Directors of Tyra Biosciences, Inc. designated Julia Rueb, Vice President, Finance, as the company's principal accounting officer, succeeding Alan Fuhrman in that role. Mr. Fuhrman continues to serve as the principal financial officer and Chief Financial Officer. This is a routine internal designation with no reported changes to executive leadership structure.

• ·Ms. Rueb, 40, has served as VP Finance since January 2024, previously Director/Senior Director of Accounting and Corporate Controller (Oct 2022-Dec 2023).
• ·Ms. Rueb holds a Master’s degree in Accounting from the University of San Diego and is a Certified Public Accountant.
• ·Ms. Rueb has no family relationships with any of the company’s directors or executive officers.
• ·Common Stock (TYRA) trades on Nasdaq Global Select Market; company is an emerging growth company.

02-04-2026

On March 30, 2026, Amie Thuener O'Toole notified Alphabet Inc. of her resignation as Vice President, Corporate Controller, and Principal Accounting Officer, effective April 9, 2026, to pursue another professional opportunity. The resignation did not result from any disagreement with the Company on matters relating to its operations, policies, or practices.

• ·Filing Date: April 2, 2026
• ·Date of earliest event reported: March 30, 2026
• ·Report signed by Kathryn W. Hall on behalf of Alphabet Inc.

02-04-2026

Nexscient, Inc. appointed Eric Sherb as Chief Financial Officer effective April 1, 2026, via a consulting agreement with EMS Consulting Services, Inc., which includes a $5,000 monthly retainer and a one-time grant of 36,000 common shares vesting over six months. Mr. Sherb, a CPA with 19 years of experience from firms like PricewaterhouseCoopers and prior CFO roles at public companies including Scienture Holdings, Inc., was engaged to provide CFO-level financial and accounting services. The agreement is terminable by either party at any time, with no family relationships or other disclosable transactions involving Mr. Sherb.

• ·Consulting agreement dated March 31, 2026.
• ·Mr. Sherb's experience includes IPOs, SPACs, de-SPACs, debt/equity financings.
• ·No family relationships with directors or officers.
• ·No transactions requiring disclosure under Item 404(a) of Regulation S-K.

02-04-2026

TFS Financial Corporation's primary subsidiary, Third Federal Savings & Loan Association of Cleveland, announced the retirement of Meredith S. Weil as Board of Directors member and Chief Financial Officer effective January 2027, following nearly 30 years with the company including roles as COO and Board member since 2014. James E. LaRocca, formerly EVP and CFO of Westfield Bank (acquired by First Financial Bancorp in November 2025), will join as Finance and Accounting Officer on June 29, 2026, and is expected to assume the CFO role. As of December 31, 2025, the company's assets totaled $17.50 billion.

• ·Third Federal founded in 1938 as a mutual association and became part of public company in 2007 (Nasdaq: TFSL)
• ·Ms. Weil served as COO from 2012-2023 and CFO since 2024
• ·Mr. LaRocca held BA in Accounting and MBA from Baldwin-Wallace University; licensed CPA in Ohio

02-04-2026

Hamilton Insurance Group, Ltd. (HG) and its subsidiary Hamilton Re, Ltd. entered into a side letter agreement effective April 1, 2026, with Two Sigma Hamilton Fund, LLC, Two Sigma Principals, LLC, and Two Sigma Investments, LP, terminating a prior commitment agreement dated July 1, 2023 (amended January 1, 2025) and establishing a Minimum Commitment Amount for investment in the Fund as the lesser of $1.8 billion or 60% of HG's net tangible assets. Investor interests are split into Sub-Series A (excess over minimum, withdrawable quarterly with 55 days' notice) and Sub-Series B (up to minimum, withdrawable monthly up to ~8.33% with 6 months' notice or phased over 12 months for larger amounts), with at least 95% of withdrawal proceeds distributed within 25 days. The agreement specifies a default allocation of approximately 70% to equity strategies and 30% to macro strategies, alongside mutual notice obligations for material events like changes in control.

• ·Withdrawal Notice for Sub-Series A: 55 calendar days prior to quarter-end Sub-Series A Withdrawal Date.
• ·Withdrawal Notice for Sub-Series B: 6 months prior to monthly Sub-Series B Withdrawal Date for up to 1/12th; larger withdrawals processed over 12-month schedule starting at 1/12th escalating to 100%.
• ·Notice events include Change in Control (>25% voting interests transfer), material business changes, or adverse law changes.
• ·Prior Commitment Agreement dated July 1, 2023, amended January 1, 2025, terminated effective April 1, 2026.

02-04-2026

TaskUs, Inc. received notice from Jacqueline D. Reses of her resignation as a Class I director, effective immediately following the 2026 Annual Meeting of Stockholders expected on or around May 21, 2026, prompting a board size reduction from nine to eight members. BCP FC Aggregator LP requested the substitution of Amit Dalmia for Amit Dixit as a Blackstone Designee and Class II director at the 2026 AGM, with Mr. Dalmia's term extending until the 2029 AGM. Neither the resignation nor substitution stems from any disagreements with the company, management, or board.

• ·Date of earliest event: March 27, 2026
• ·Proxy Statement to be filed with SEC on or around April 10, 2026
• ·Substitution pursuant to Amended and Restated Stockholders Agreement dated June 15, 2021

02-04-2026

Bimini Capital Management, Inc. (BMNM) completed the acquisition of 80% of the fully diluted equity interests in Tom Johnson Investment Management, LLC (TJIM), a registered investment adviser, for a total purchase price of $12,318,492, with $12 million paid in cash at closing on April 1, 2026. TJIM adds approximately $1.63 billion in assets under management across equity and fixed income markets. The transaction includes a potential future purchase of the remaining 20% interest after the third anniversary or seller's departure, along with new employment agreements for key staff.

• ·Balance of purchase price payable on or before first anniversary of closing.
• ·Option or obligation to acquire remaining 20% of TJIM equity after third anniversary or principal seller ceasing employment.
• ·Three-year employment agreement for principal seller; employment agreements for all TJIM staff.
• ·Potential equity ownership offers to certain TJIM staff for retention.

02-04-2026

Hoth Therapeutics, Inc. entered into a definitive agreement for a registered direct offering of 2,857,144 shares of common stock (or equivalents) at $0.70 per share, expecting aggregate gross proceeds of approximately $2.0 million before fees. In a concurrent private placement, the company issued unregistered warrants to purchase up to 2,857,144 shares at $0.85 per share, potentially providing an additional $2.4 million if fully exercised on a cash basis. Net proceeds will support general corporate purposes, including working capital, with closing expected on or about April 2, 2026.

• ·Offering price: $0.70 per share of common stock (or per common stock equivalent)
• ·Warrant exercise price: $0.85 per share
• ·Warrants exercisable six months after issuance and expire five and one-half years after issuance
• ·Shelf registration on Form S-3 (File No. 333-291566), originally filed November 17, 2015, effective December 4, 2025
• ·H.C. Wainwright & Co. acting as exclusive placement agent

02-04-2026

On March 27, 2026, the Board of Directors of MAIA Biotechnology, Inc. approved one-time bonus payments totaling $362,610, including $312,610 to CEO Vlad Vitoc and $50,000 to Head of Finance Jeffrey Himmelreich, in recognition of their efforts in a recent capital raise. The payments were made on March 31, 2026. No other material changes in officers or directors were reported.

• ·Bonus payments approved under Item 5.02 for compensatory arrangements related to recent capital raise.
• ·Filing signed by Vlad Vitoc on April 2, 2026.

02-04-2026

Motorsport Games Inc. entered into employment agreements on March 27, 2026, appointing Stephen Hood as Chief Executive Officer with an annual base salary of £378,000 and eligibility for a 50% target bonus, and Stanley Beckley as Chief Financial Officer with a $300,000 base salary and 25% target bonus. Both executives are eligible for equity awards under the 2021 Equity Incentive Plan and subject to restrictive covenants. No prior executive departures are mentioned in the filing.

• ·Hood Employment Agreement: 6-month notice by employee, 18-month by company; payment in lieu option; non-compete for 12 months post-employment.
• ·Beckley Employment Agreement: 6-month severance without cause; full equity vesting acceleration on change in control termination within 12 months; non-compete for 18 months post-employment.

02-04-2026

On March 27, 2026, Cardiff Oncology, Inc. entered into separation agreements with former CEO Dr. Mark Erlander and former CFO James Levine following their earlier step-downs, entailing significant severance costs including 12 months of base salary continuation ($635,000 for Erlander and $490,000 for Levine), payment of their 2025 bonuses ($122,238 and $61,740 respectively), pro-rated 50% target bonuses for 2026, and up to 12 months of healthcare benefits. Dr. Erlander also signed a consulting agreement with continued stock option vesting until June 2026 and exercisability for 12 months thereafter, while Levine's vested options are exercisable for 12 months post-separation. Dr. Erlander resigned as a director on the same date.

• ·Both executives agreed to general release and confidentiality provisions.
• ·Dr. Erlander's stock options continue to vest until June 2026, then exercisable for 12 months.
• ·Mr. Levine's vested stock options exercisable for 12 months after March 27, 2026.

02-04-2026

Cable One, Inc. announced on March 27, 2026, that Kenneth E. Johnson will step down as Chief Operating Officer effective May 1, 2026, transitioning to a senior advisor role until January 2027. The departure is not due to any disagreement regarding the company's operations, policies, practices, controls, or financial/accounting matters. No successor has been named in the filing.

• ·Company headquartered at 210 E. Earll Drive, Phoenix, Arizona 85012
• ·Common Stock (CABO) traded on New York Stock Exchange

02-04-2026

Option Care Health, Inc. entered into the Fifth Amendment to its Amended and Restated First Lien Credit Agreement on March 30, 2026, adding $450 million in Incremental Revolving Credit Commitments and increasing total Revolving Credit Commitments to $850 million from a prior $400 million (a 112.5% increase). Bank of America, N.A. serves as administrative agent, with BofA Securities, Inc., JPMorgan Chase Bank, N.A., and Truist Securities, Inc. as joint lead arrangers and bookrunners. The amendment reaffirms all existing guarantees and security interests, with no reported issues such as Events of Default.

• ·Amendment effective upon conditions including execution of documents, legal opinions, certificates of good standing, board resolutions, solvency certificate from CFO, payment of fees, true representations/warranties, no Event of Default, and KYC/PATRIOT Act compliance.
• ·Previous amendments: First (June 8, 2023), Second (December 7, 2023), Third (May 8, 2024), Fourth (September 22, 2025).

02-04-2026

The Brand House Collective, Inc. (TBHC), a Tennessee corporation, completed a merger on April 2, 2026, in which Knight Merger Sub II, Inc., a Delaware corporation, merged with and into TBHC pursuant to the General Corporation Law of Delaware §252. TBHC is the surviving corporation, retaining its name and Articles of Incorporation, with an executed Merger Agreement on file at its principal place of business. The certificate was signed by Amy Sullivan, President and Chief Executive Officer.

• ·Principal place of business of Surviving Corporation: 5310 Maryland Way, Brentwood, TN 37027
• ·Merger governed by Delaware General Corporation Law §252
• ·Surviving Corporation irrevocably appoints Delaware Secretary of State as agent for service of process

02-04-2026

Borealis Foods Inc. entered a Forbearance and Amendment Agreement on March 27, 2026, with Frontwell Capital Partners Inc. to address multiple Specified Defaults under its Credit Agreement, including overadvances, failure to maintain Excess Availability, issuance of $26.7 million in prohibited unsecured notes, and reporting failures, with outstanding Obligations of $16,116,215.30 as of March 25, 2026. The agreement increases financial costs via a default interest rate (up 2.00% since December 9, 2025), higher Applicable Margins (Revolving Loans to 6.50% from 4.50%, Term Loan to 6.75% from 4.75%), a $50,000 forbearance fee, and a $600,000 reserve, while blocking payments on the unsecured notes and requiring milestones like a Refinancing Plan by April 9, 2026. The company appointed Jeffrey T. Varsalone as Chief Restructuring Officer effective March 30, 2026, with broad powers, signaling severe financial distress during the Forbearance Period ending April 27, 2026.

• ·Forbearance Period commences March 27, 2026, and ends April 27, 2026, unless earlier terminated on Forbearance Default.
• ·Milestones include CRO retention by March 30, 2026, and delivery of Refinancing Plan by April 9, 2026.
• ·VRS hourly rates range from $325 to $925 per hour; no success or contingent fees.
• ·Blocked Notes holders include Chairman Barthelemy Helg, CEO Reza Soltanzadeh's controlled entities, and former SPAC sponsor Oxus Capital PTE LTD.

02-04-2026

Silo Pharma, Inc. entered into an asset purchase agreement dated March 31, 2026 (Item 1.01 references July 29, 2025) with Many Ads Inc. to acquire the QwikAgents web-based application software, including source code and object code, along with domain names qwikagents.com, qwikagents.ai, and qwikagents.co. In consideration, the Company issued 2,100,000 shares of its common stock (par value $0.0001 per share) in an unregistered sale under Section 4(a)(2) of the Securities Act. No financial valuation or performance metrics for the assets were disclosed.

• ·Shares have par value $0.0001 per share
• ·Transaction relies on Section 4(a)(2) of the Securities Act for exemption from registration
• ·Seller provides indemnification for misrepresentations, breaches, IP infringement, and gross negligence
• ·Software includes identified Open Source Software components per Exhibit B, with one LGPL-licensed dependency

02-04-2026

Minerva Neurosciences, Inc. (NERV) announced a leadership transition with the appointment of Jim O’Connor as Chief Business Officer and General Counsel effective April 21, 2026, as Geoff Race steps down from his role as President after 16 years but will continue as a consultant. Dr. Remy Luthringer expressed gratitude for Race's foundational contributions and confidence in O’Connor to advance roluperidone through its next Phase 3 trial. O’Connor brings over 20 years of experience, including negotiating >$130 million in financings and FDA regulatory successes.

• ·Jim O’Connor previously served at Axena Health in roles including General Counsel & Chief Operating Officer, General Counsel & Chief Financial Officer, and Interim CEO.
• ·O’Connor oversaw FDA 510(k) clearance, label expansions, and FDA Breakthrough Device Designation via appeal.
• ·Geoff Race joined Minerva in 2010 and held roles including EVP & CFO and Chief Business Officer.
• ·Filing date: April 02, 2026

02-04-2026

Bank of Marin Bancorp (Nasdaq: BMRC) announced a webcast of its Q1 2026 earnings call on April 27, 2026, at 8:30 a.m. PT, where President and CEO Tim Myers and EVP and CFO Dave Bonaccorso will discuss results for the fiscal first quarter ended March 31, 2026. The company, with $3.9 billion in assets, operates 27 branches and eight commercial banking offices in Northern California. A replay will be available on the company's investor relations website.

• ·Founded in 1990 and headquartered in Novato, CA.
• ·Consistently ranked one of the “Top Corporate Philanthropists" by San Francisco Business Times since 2003.
• ·Ranked top 13 in Sacramento Business Journal’s 2025 Corporate Direct Giving List.
• ·Recognized as one of North Bay Business Journal’s “Best Places to Work” in 2025.
• ·Inducted into North Bay Biz’s “Best of” Hall of Fame in 2024.
• ·Included in the Russell 2000 Small-Cap Index and Nasdaq ABA Community Bank Index.

02-04-2026

Booking Holdings Inc. announced the appointment of Caroline Sullivan as Senior Vice President, Chief Accounting Officer, and Controller, effective April 29, 2026. Ms. Sullivan, aged 57, has prior experience as Vice President at Elevance Health (June 2025–March 2026), Senior Vice President, Chief Accounting Officer and Corporate Controller at Moody's Corporation (2018–2025), and roles at Bank of America, Morgan Stanley, Allied Irish Bank, and Ernst & Young. Compensation package includes an initial base salary of $525,000, target annual bonus of 75% of base salary, equity grants with $3,000,000 total grant date fair value, and a $300,000 signing bonus.

• ·RSUs and new hire RSUs vest in three equal annual installments, with pro rata vesting on termination without cause or disability, and full vesting on death.
• ·PSU award vests based on service and performance provisions consistent with 2027 executive grants under the 1999 Omnibus Plan.
• ·Entered into Non-Competition and Non-Solicitation Agreement and Employee Confidentiality and Assignment Agreement.
• ·Severance on termination without cause includes 1x base salary and target bonus, pro-rated bonus if after June 30, 12 months health benefits, and prior earned bonus.